Literature DB >> 30721638

Advances in surgical strategies for prolapse.

A Giannini1, M Caretto1, E Russo1, P Mannella1, T Simoncini1.   

Abstract

Pelvic floor dysfunctions are a complex condition in elderly women; pelvic organ prolapse, urinary or fecal incontinence, constipation, pelvic pain, and sexual dysfunction are common problems. The goal of surgical treatment is functional reconstruction with symptom management and repair of anatomic defects. The recent advancements in surgical treatment of pelvic floor dysfunction allow several good options for choosing the best surgery for each patient. The vaginal procedure is traditionally the gold standard approach for elderly patients, but abdominal surgery is increasing as a mini-invasive approach and the robotic approach is gaining acceptance for treatment of pelvic floor dysfunctions. In elderly individuals, a multitude of factors affects the final result of any reconstructive surgery such as postmenopausal or aging-associated changes in muscle tone and nerve function or changes in the function of the bladder or of the rectum: an understanding of the underlining functional status of pelvic organs is very important in aging women before proceeding to surgery. In this context, pelvic floor dysfunction, particularly in elderly women, should be addressed in a multidisciplinary manner and, at the forefront, centers for surgical planning could be helpful to perform safer, patient-tailored surgery.

Entities:  

Keywords:  Pelvic organ prolapse; aging; pelvic floor dysfunction; surgery; tailoring

Mesh:

Year:  2019        PMID: 30721638     DOI: 10.1080/13697137.2018.1543266

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  1 in total

1.  Abdominal ventral rectopexy with colectomy for obstructed defecation syndrome: An alternative option for selected patients.

Authors:  Li Wang; Chun-Xue Li; Yue Tian; Jing-Wang Ye; Fan Li; Wei-Dong Tong
Journal:  World J Clin Cases       Date:  2020-12-06       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.